Please note that this course has been rearranged to start in February 2025
A quality assured, comprehensive course introducing the theory, methodology and delivery of IONM.
This interactive course is designed to provide a safe and engaging learning environment for healthcare professionals seeking to enhance their skills in paediatric ECG interpretation and recognition of arrhythmia.
Please note that this course has been moved to Wednesday 27th November 2024
This course will introduce the science behind many forms of immunotherapy, including immune checkpoint inhibitors, treatment vaccines, and CAR T cells.
During this two day course delegates will learn the basic casting techniques and skills specifically required for CPD surgical trainees development within the NHS.
This two-day course will teach the different methods of wound debridement, with a special focus on conservative sharp debridement, facilitated by the Newcastle Hospitals’ Tissue Viability Team with guest speaker specialists from Dermatology, Plastics, Podiatry as well as the physiology and anatomy faculty of Newcastle University.
This 5 day course aims to provide learners with the knowledge and skills required to manage the care of congenital heart disease patients with complex anatomy and physiology throughout their lifetime.
The fundamental idea of precision medicine is to offer each cancer patient a treatment approach that is tailored to the unique biology and genetics of their disease. This two session course provides an understanding of the concepts that underlie precision cancer medicine and both its promise and limitations.
This unique course introduces therapists to the One-Handed Therapy Intervention (OTI) Programme. The OTI Programme is a tool kit developed by therapists for therapists to use with families who have a child aged 2 – 4 years with hemiplegia.
A unique Specialist Consultant taught interactive educational experience for the referring and reporting of Cone Beam CT
This 3-hour virtual course emphasises the progress made in developing novel immunotherapies for solid tumours, such as CAR T cell therapy, TCR-engineered T cell therapy, tumour infiltrating lymphocytes, T cell engagers, and vaccine-based treatments.